Gentex Corporation - GNTX

GNTX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
GNTX	1.7	3.8	-6.6	-5.8	-19.5	-13.6	-19.7	-9.7	60.7	27440.4
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare GNTX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	GNTX
name	Gentex Corporation
price	27.97
changes percentage	1.71
change	0.47
day low	27.57
day high	28.09
year high	37.58
year low	26.58
market cap	6361273040
price avg 50	29.54
price avg 200	31.59
exchange	NASDAQ
volume	1337756
avg volume	1431460
open	27.62
previous close	27.50
eps	1.89
pe	14.80
earnings announcement	2025-01-31T13:30:00.000+0000
shares outstanding	227432000
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 68.3%

Overall Quarterly Financial Health: 59.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000355811
revenue	2299215044	1918958043	19.82
gross profit	762630008	609814185	25.06
gross profit ratio	0.33	0.32	4.38
research and development expenses	154359700	133308804	15.79
operating expenses	266898955	239808059	11.30
interest income	13498351	0	NaN
interest expense	0	0	NaN
ebitda	589052245	466574569	26.25
ebitdaratio	0.26	0.19	32.87
operating income	495731053	273437683	81.30
operating income ratio	0.22	0.14	51.31
net income	428403272	318757352	34.40
net income ratio	0.19	0.17	12.17
eps	1.84	1.36	35.29

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,299 million in 2023 from 1,919 million in 2022 representing a change of 19.82%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 763 million in 2023 from 610 million in 2022 representing a change of 25.06%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 154 million in 2023 from 133 million in 2022 representing a change of 15.79%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 589 million in 2023 from 467 million in 2022 representing a change of 26.25%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 496 million in 2023 from 273 million in 2022 representing a change of 81.3%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 428 million in 2023 from 319 million in 2022 representing a change of 34.4%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.84 in 2023 from 1.84 in 2022 representing a change of 35.29%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 267 million in 2023 from 240 million in 2022 representing a change of 11.3%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000355811
revenue	608525777	572925778	6.21
gross profit	204063635	188563309	8.22
gross profit ratio	0.34	0.33	1.89
research and development expenses	48225968	44003994	9.59
operating expenses	78335483	73679287	6.32
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	168400514	138872386	21.26
ebitdaratio	0.28	0.2	38.01
operating income	125728152	114884020	9.44
operating income ratio	0.21	0.2	3.04
net income	120944946	86040438	40.57
net income ratio	0.2	0.15	32.34
eps	0.53	0.38	39.47

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 609 million in 2024Q3 from 573 million in 2024Q2 representing a change of 6.21%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 204 million in 2024Q3 from 189 million in 2024Q2 representing a change of 8.22%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 48 million in 2024Q3 from 44 million in 2024Q2 representing a change of 9.59%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 168 million in 2024Q3 from 139 million in 2024Q2 representing a change of 21.26%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 126 million in 2024Q3 from 115 million in 2024Q2 representing a change of 9.44%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 0.53 in 2024Q3 from 0.53 in 2024Q2 representing a change of 39.47%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 78 million in 2024Q3 from 74 million in 2024Q2 representing a change of 6.32%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 121 million in 2024Q3 from 86 million in 2024Q2 representing a change of 40.57%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000355811
total assets	2611437552	2327229924	12.21
total liabilities	298920483	261437103	14.34
total equity	2312517069	2065792821	11.94
cash and cash equivalents	226435019	214754638	5.44
short term investments	14356476	23007385	-37.60
long term investments	299080876	202331983	47.82
total current assets	997738153	948652376	5.17
total non current assets	1613699399	1378577548	17.06
total current liabilities	271608976	250552752	8.40
total non current liabilities	27311507	10884351	150.92
common stock	13887326	14050160	-1.16
retained earnings	1336940990	1148386272	16.42
total debt	3570215	0	NaN

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,611 million in 2023 from 2,327 million in 2022 representing a change of 12.21%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 2,313 million in 2023 from 2,066 million in 2022 representing a change of 11.94%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 226 million in 2023 from 215 million in 2022 representing a change of 5.44%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 998 million in 2023 from 949 million in 2022 representing a change of 5.17%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,337 million in 2023 from 1,148 million in 2022 representing a change of 16.42%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 299 million in 2023 from 261 million in 2022 representing a change of 14.34%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 14 million in 2023 from 23 million in 2022 representing a change of -37.6%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 272 million in 2023 from 251 million in 2022 representing a change of 8.4%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 14 in 2023 from 14 in 2022 representing a change of -1.16%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 4 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000355811
total assets	2735296843	2738285062	-0.11
total liabilities	317669501	337985535	-6.01
total equity	2417627342	2400299527	0.72
cash and cash equivalents	179639743	260241950	-30.97
short term investments	20462581	15534338	31.72
long term investments	325561578	308051778	5.68
total current assets	1045684218	1083883853	-3.52
total non current assets	1689612625	1654401208	2.13
total current liabilities	283164653	304728500	-7.08
total non current liabilities	34504848	33257035	3.75
common stock	13646597	13813772	-1.21
retained earnings	1405918157	1394446595	0.82
total debt	2079966	5535594	-62.43

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 2,735 million in 2024Q3 from 2,738 million in 2024Q2 representing a change of -0.11%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 180 million in 2024Q3 from 260 million in 2024Q2 representing a change of -30.97%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 1,046 million in 2024Q3 from 1,084 million in 2024Q2 representing a change of -3.52%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 14 in 2024Q3 from 14 in 2024Q2 representing a change of -1.21%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 318 million in 2024Q3 from 338 million in 2024Q2 representing a change of -6.01%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 2,418 million in 2024Q3 from 2,400 million in 2024Q2 representing a change of 0.72%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 20 million in 2024Q3 from 16 million in 2024Q2 representing a change of 31.72%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 283 million in 2024Q3 from 305 million in 2024Q2 representing a change of -7.08%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 1,406 million in 2024Q3 from 1,394 million in 2024Q2 representing a change of 0.82%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2 million in 2024Q3 from 6 million in 2024Q2 representing a change of -62.43%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000355811
net change in cash	7680381	-43557032	117.63
operating cash flow	537249592	338200529	58.86
free cash flow	353571132	191767406	84.37
capital expenditure	-183678460	-146433123	-25.44
depreciation and amortization	93321192	96568443	-3.36
deferred income tax	-17735110	-17777777	0.24
stock based compensation	39197422	30228606	29.67
accounts payables	40951490	37423488	9.43
inventory	2127242	-88092828	102.41
acquisitions net	-90020050	-33830274	-166.09
investments in property plant and equipment	-183678460	-146433123	-25.44
net cash used for investing activites	-299416320	-172738508	-73.34
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-147401103	-112529406	-30.99
dividends paid	-112150060	-113091921	0.83
net cash used provided by financing activities	-230152891	-209019053	-10.11
cash at end of period	226435019	218754638	3.51
accounts receivables	-45251116	-26698846	-69.49
cash at beginning of period	218754638	262311670	-16.61

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 8 million in 2023 from -44 million in 2022 representing a change of 117.63%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 537 million in 2023 from 338 million in 2022 representing a change of 58.86%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 354 million in 2023 from 192 million in 2022 representing a change of 84.37%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -184 million in 2023 from -146 million in 2022 representing a change of -25.44%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -45 million in 2023 from -27 million in 2022 representing a change of -69.49%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -112 million in 2023 from -113 million in 2022 representing a change of 0.83%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -18 million in 2023 from -18 million in 2022 representing a change of 0.24%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 39 million in 2023 from 30 million in 2022 representing a change of 29.67%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 41 million in 2023 from 37 million in 2022 representing a change of 9.43%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000355811
operating cash flow	84690307	129250315	-34.48
free cash flow	45358595	96651010	-53.07
capital expenditure	-39331712	-32599305	-20.65
depreciation and amortization	22945162	23988364	-4.35
deferred income tax	1262032	-7594021	116.62
stock based compensation	9540105	10922998	-12.66
accounts receivables	-15244187	35025450	-143.52
accounts payables	-17318424	11237722	-254.11
inventory	61019277	-26955061	326.37
acquisitions net	-127000	117500	-208.09
investments in property plant and equipment	-40824960	-32599305	-25.23
net cash used for investing activites	-44804117	-46936406	4.54
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-96642935	-46741373	-106.76
dividends paid	-27627507	-27743441	0.42
net cash used provided by financing activities	-120488398	-71076492	-69.52
net change in cash	-80602208	11237416	-817.27
cash at end of period	179639743	260241950	-30.97
cash at beginning of period	260241950	249004534	4.51

Overall Score of Quarterly Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -81 million in 2024Q3 from 11 million in 2024Q2 representing a change of -817.27%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 85 million in 2024Q3 from 129 million in 2024Q2 representing a change of -34.48%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 45 million in 2024Q3 from 97 million in 2024Q2 representing a change of -53.07%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 1 million in 2024Q3 from -8 million in 2024Q2 representing a change of 116.62%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 17 million in 2024Q3 from 11 million in 2024Q2 representing a change of -254.11%. This indicates that the company has increased its outstanding obligations to its suppliers.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -39 million in 2024Q3 from -33 million in 2024Q2 representing a change of -20.65%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 10 million in 2024Q3 from 11 million in 2024Q2 representing a change of -12.66%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -15 million in 2024Q3 from 35 million in 2024Q2 representing a change of -143.52%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -28 million in 2024Q3 from -28 million in 2024Q2 representing a change of 0.42%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	10.02	8.31	20.56
net income per share	1.87	1.38	35.23
operating cash flow per share	2.34	1.47	59.84
free cash flow per share	1.54	0.83	85.52
cash per share	1.05	1.03	1.90
book value per share	10.08	8.95	12.64
tangible book value per share	7.38	6.24	18.25
shareholders equity per share	10.08	8.95	12.64
interest debt per share	0.02	0	NaN
market cap	7492382944.14	6294605740.11	19.03
enterprise value	7269518140.14	6079851102.11	19.57
pe ratio	17.49	19.75	-11.44
price to sales ratio	3.26	3.28	-0.66
pocfratio	13.95	18.61	-25.07
pfcf ratio	21.19	32.82	-35.44
pb ratio	3.24	3.05	6.33
ptb ratio	3.24	3.05	6.33
ev to sales	3.16	3.17	-0.21
enterprise value over ebitda	12.34	13.03	-5.29
ev to operating cash flow	13.53	17.98	-24.73
ev to free cash flow	20.56	31.7	-35.15
earnings yield	0.06	0.05	12.91
free cash flow yield	0.05	0.03	54.90
debt to equity	0.0	0	NaN
debt to assets	0.0	0	NaN
net debt to ebitda	-0.38	-0.46	17.80
current ratio	3.67	3.79	-2.98
interest coverage	0	0	NaN
income quality	1.25	1.06	18.20
dividend yield	0.01	0.02	-16.69
payout ratio	0.26	0.35	-26.21
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.07	0.07	-3.36
intangibles to total assets	0.24	0.27	-11.68
capex to operating cash flow	0.34	0.43	-21.04
capex to revenue	0.08	0.08	4.69
capex to depreciation	1.97	1.52	29.80
stock based compensation to revenue	0.02	0.02	8.22
graham number	20.58	16.68	23.42
roic	0.18	0.11	58.21
return on tangible assets	0.22	0.19	14.83
graham net net	1.68	1.67	0.25
working capital	726129177	698099624	4.02
tangible asset value	1691889977	1439580292	17.53
net current asset value	698817670	687215273	1.69
invested capital	1999633941	1874345189	6.68
average receivables	299151810	263144329	13.68
average payables	168069433	125041487	34.41
average inventory	403416649	360313856	11.96
days sales outstanding	51.09	52.59	-2.86
days payables outstanding	43.8	42.31	3.54
days of inventory on hand	95.6	112.74	-15.20
receivables turnover	7.14	6.94	2.94
payables turnover	8.33	8.63	-3.41
inventory turnover	3.82	3.24	17.92
roe	0.19	0.15	20.06
capex per share	0.8	0.63	26.21

• Positive

  ROE: Return on Equity (ROE) increased to 0.19 on 2023-12-31 from 0.15 on 2022-12-31, representing a change of 20.06%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 17.49 on 2023-12-31 from 19.75 on 2022-12-31, representing a change of -11.44%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 3.67 on 2023-12-31 from 3.79 on 2022-12-31, representing a change of -2.98%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
GNTX
calendar year	2024	2024	NaN
revenue per share	2.68	2.51	6.68
net income per share	0.53	0.38	41.18
operating cash flow per share	0.37	0.57	-34.19
free cash flow per share	0.2	0.42	-52.87
cash per share	0.88	1.21	-27.12
book value per share	10.65	10.53	1.16
tangible book value per share	8.27	7.83	5.50
shareholders equity per share	10.65	10.53	1.16
interest debt per share	0.01	0.02	-62.26
market cap	6737927842.61	7660695303.28	-12.05
enterprise value	6560368065.61	7405988947.28	-11.42
pe ratio	13.93	22.26	-37.43
price to sales ratio	11.07	13.37	-17.19
pocfratio	79.56	59.27	34.23
pfcf ratio	148.55	79.26	87.42
pb ratio	2.79	3.19	-12.68
ptb ratio	2.79	3.19	-12.68
ev to sales	10.78	12.93	-16.60
enterprise value over ebitda	38.96	53.33	-26.95
ev to operating cash flow	77.46	57.3	35.19
ev to free cash flow	144.63	76.63	88.75
earnings yield	0.02	0.01	59.82
free cash flow yield	0.01	0.01	-46.64
debt to equity	0.0	0.0	-62.69
debt to assets	0.0	0.0	-62.38
net debt to ebitda	-1.05	-1.83	42.51
current ratio	3.69	3.56	3.82
interest coverage	0	0	NaN
income quality	0.69	1.52	-54.64
dividend yield	0.0	0.0	13.22
payout ratio	0.23	0.32	-29.16
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.08	0.08	3.18
intangibles to total assets	0.2	0.22	-11.75
capex to operating cash flow	0.46	0.25	84.13
capex to revenue	0.06	0.06	13.59
capex to depreciation	1.71	1.36	26.14
stock based compensation to revenue	0.02	0.02	-17.77
graham number	11.3	9.46	19.51
roic	0.04	0.04	7.77
return on tangible assets	0.06	0.04	36.09
graham net net	1.65	1.75	-5.88
working capital	762519565	779155353	-2.14
tangible asset value	1875917676	1785772092	5.05
net current asset value	728014717	745898318	-2.40
invested capital	2007812720	2073169745	-3.15
average receivables	331451844.5	324078406	2.28
average payables	194304066.5	198869226.5	-2.30
average inventory	456401662.5	450014774.5	1.42
days sales outstanding	52.7	48.16	9.44
days payables outstanding	40.63	48.24	-15.76
days of inventory on hand	99.98	108.53	-7.88
receivables turnover	1.71	1.87	-8.62
payables turnover	2.21	1.87	18.71
inventory turnover	0.9	0.83	8.55
roe	0.05	0.04	39.56
capex per share	0.17	0.14	21.18

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of 39.56%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 13.93 on 2024-09-30 Q3 from 22.26 on 2024-06-30 Q2, representing a change of -37.43%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 3.69 on 2024-09-30 Q3 from 3.56 on 2024-06-30 Q2, representing a change of 3.82%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q3 from 0.00 on 2024-06-30 Q2, representing a change of -62.69%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 37.93 which is higher than current price 27.97, indicates the company may be undervalued.